Transforming Health Systems for Universal Care

Abstract*

The development objective of the Transforming Health Systems for Universal Care Project for Kenya is to improve utilization and quality of primary health care (PHC) services with a focus on reproductive, maternal, newborn, child, and adolescent health (RMNCAH) services. The project comprises of three components. The first component, improving PHC results aims to improve the delivery, utilization, and quality of PHC services at the county level with... Show More

Development Objective

The project development objective is to improve utilization and quality of primary health care services with a focus on reproductive, maternal, newborn, child and adolescent health services and to provide immediate and effective response to an eligible crisis or emergency .

Key Details

Project Details

Project ID
P152394
Status
Closed
Team Leader
Toni Kuguru , Jane Chuma
Borrower 2
Republic of Kenya

Country
Kenya
Disclosure Date
May 13, 2015
Approval Date
(as of board presentation)
June 15, 2016
Effective Date
July 4, 2016

Total Project Cost 1
US$ 191.10 million
Implementing Agency
Ministry of Health
Region
Eastern and Southern Africa
Fiscal Year 3
2016

Commitment Amount
US$ 191.10 million
Environmental Category
B
Last Update Date
May 29, 2024
Closing Date
September 30, 2023

Consultant Services required
Yes
Last Stage Reached
BANK APPROVED

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control1%
- FY17 - Pandemic Response1%
FY17 - Health Systems and Policies90%
- FY17 - Child Health30%
- FY17 - Health System Strengthening30%
- FY17 - Reproductive and Maternal Health30%
FY17 - Nutrition and Food Security10%
- FY17 - Food Security5%
- FY17 - Nutrition5%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
Japan Policy and Human Resources Development Fund	1.10
IDA Credit	150.00
Global Financing Facility	40.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	150.00
IBRD + IDA Commitment	150.00

Lending Instrument
Grant Amount	41.10
Total Project Cost**	191.10

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

No data available.

Detailed Financial Activity as of February 28, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Feb 15, 2023	IDA-58360	Int Charges	483,460.94
Feb 15, 2023	IDA-58360	Int Charges	483,460.94
Feb 7, 2023	IDA-58360	Loan Disb	-274,338.38
Feb 9, 2023	IDA-58360	Loan Disb	-105,040.01
Aug 15, 2023	IDA-58360	Int Charges	13,261.67
Aug 15, 2023	IDA-58360	Int Charges	13,261.67
Aug 15, 2023	IDA-58360	Loan Repay	2,204,623.00
Aug 15, 2023	IDA-58360	Int Charges	486,464.66
Aug 15, 2023	IDA-58360	Int Charges	486,464.66
Aug 15, 2022	IDA-58360	Int Charges	1,575.50
Aug 15, 2022	IDA-58360	Int Charges	1,575.50
Aug 15, 2022	IDA-58360	Loan Repay	2,184,832.80
Aug 15, 2022	IDA-58360	Int Charges	509,605.30
Aug 15, 2022	IDA-58360	Int Charges	509,605.30
Jul 1, 2022	IDA-58360	Loan Disb	-434,230.20
Jul 25, 2022	IDA-58360	Loan Disb	-2,144,375.00
Feb 15, 2022	IDA-58360	Int Charges	529,847.94
Feb 15, 2022	IDA-58360	Int Charges	529,847.94
Aug 30, 2018	IDA-58360	Loan Disb	504,738.16
Aug 9, 2018	IDA-58360	Loan Disb	2,208,797.80
Sep 10, 2018	IDA-58360	Loan Disb	164,627.02
Jun 19, 2018	IDA-58360	Loan Disb	265,589.12
Jun 19, 2018	IDA-58360	Loan Disb	272,160.00
Aug 27, 2018	IDA-58360	Int Charges	1,338.61
Aug 27, 2018	IDA-58360	Int Charges	1,338.61
Aug 27, 2018	IDA-58360	Int Charges	66,412.69
Aug 27, 2018	IDA-58360	Int Charges	66,412.69
Feb 27, 2017	IDA-58360	Loan Disb	2,000,000.00
Feb 27, 2017	IDA-58360	Loan Disb	2,500,000.00
Feb 23, 2017	IDA-58360	Loan Disb	7,500,000.00
Aug 15, 2017	IDA-58360	Int Charges	47,408.17
Oct 6, 2017	IDA-58360	Loan Disb	626,877.94
Aug 15, 2017	IDA-58360	Int Charges	47,408.17
Aug 15, 2017	IDA-58360	Int Charges	43.29
Aug 15, 2017	IDA-58360	Int Charges	43.29
Mar 13, 2018	IDA-58360	Int Charges	890.41
Mar 13, 2018	IDA-58360	Int Charges	890.41
Mar 13, 2018	IDA-58360	Int Charges	52,657.74
Mar 13, 2018	IDA-58360	Int Charges	52,657.74
Feb 21, 2018	IDA-58360	Loan Disb	295,382.88
Mar 21, 2018	IDA-58360	Loan Disb	49,207.31
Apr 25, 2018	IDA-58360	Loan Disb	1,511,201.50
Mar 28, 2018	IDA-58360	Loan Disb	19,348.57
Feb 28, 2018	IDA-58360	Loan Disb	2,240,805.50
Feb 13, 2017	IDA-58360	Loan Disb	1,000,000.00
Jan 24, 2020	IDA-58360	Loan Disb	474,665.40
Feb 15, 2020	IDA-58360	Int Charges	1,560.52
Feb 15, 2020	IDA-58360	Int Charges	1,560.52
Feb 15, 2020	IDA-58360	Int Charges	190,353.03
Feb 15, 2020	IDA-58360	Int Charges	190,353.03
Apr 8, 2020	IDA-58360	Loan Disb	5,000,000.00
Jun 5, 2020	IDA-58360	Loan Disb	548,427.25
Jun 15, 2020	IDA-58360	Loan Disb	1,700,085.00
Oct 7, 2019	IDA-58360	Loan Disb	1,603,800.00
Sep 3, 2019	IDA-58360	Loan Disb	5,585,724.50
Nov 18, 2019	IDA-58360	Loan Disb	31,197.50
Jan 28, 2020	IDA-58360	Loan Disb	839,949.50
Jan 28, 2020	IDA-58360	Loan Disb	8,205,925.00
Dec 9, 2019	IDA-58360	Loan Disb	12,325,067.00
Dec 6, 2019	IDA-58360	Loan Disb	1,314,310.10
Mar 19, 2020	IDA-58360	Loan Disb	5,000,000.00
Mar 7, 2019	IDA-58360	Int Charges	101,183.61
Mar 7, 2019	IDA-58360	Int Charges	101,183.61
May 21, 2019	IDA-58360	Loan Disb	940,155.50
May 20, 2019	IDA-58360	Loan Disb	2,952,627.50
Aug 30, 2019	IDA-58360	Int Charges	5,575.06
Aug 30, 2019	IDA-58360	Int Charges	5,575.06
Aug 30, 2019	IDA-58360	Int Charges	136,875.45
Aug 30, 2019	IDA-58360	Int Charges	136,875.45
Nov 19, 2019	IDA-58360	Loan Disb	1,500,089.60
Jan 16, 2019	IDA-58360	Loan Disb	6,000,000.00
Dec 18, 2018	IDA-58360	Loan Disb	369,164.70
Jan 14, 2019	IDA-58360	Loan Disb	1,143,195.00
May 3, 2019	IDA-58360	Loan Disb	338,405.97
Mar 7, 2019	IDA-58360	Int Charges	558.03
Mar 7, 2019	IDA-58360	Int Charges	558.03
Mar 23, 2018	IDA-58360	Loan Disb	2,000.01
Aug 3, 2018	IDA-58360	Loan Disb	134,260.02
Aug 3, 2018	IDA-58360	Loan Disb	139,915.39
May 23, 2018	IDA-58360	Loan Disb	544,320.00
Aug 8, 2018	IDA-58360	Loan Disb	2,094,028.20
Aug 30, 2018	IDA-58360	Loan Disb	3,343,880.80
Feb 15, 2022	IDA-58360	Int Charges	13,011.30
Feb 15, 2022	IDA-58360	Int Charges	13,011.30
Aug 15, 2021	IDA-58360	Int Charges	19,151.70
Aug 15, 2021	IDA-58360	Int Charges	19,151.70
Aug 15, 2021	IDA-58360	Int Charges	442,101.88
Aug 15, 2021	IDA-58360	Int Charges	442,101.88
Sep 24, 2021	IDA-58360	Loan Disb	9,605,109.00
Sep 23, 2021	IDA-58360	Loan Disb	1,714,920.40
Aug 31, 2021	IDA-58360	Loan Disb	297,000.00
Jun 18, 2021	IDA-58360	Loan Disb	467,538.53
May 4, 2021	IDA-58360	Loan Disb	499,392.00
May 27, 2021	IDA-58360	Loan Disb	27,501.49
Jun 22, 2021	IDA-58360	Loan Disb	3,295,280.50
Jun 22, 2021	IDA-58360	Loan Disb	13,688,544.00
Dec 28, 2020	IDA-58360	Loan Disb	10,373,854.00
Feb 4, 2021	IDA-58360	Loan Disb	1,042,231.06
Apr 8, 2021	IDA-58360	Loan Disb	2,127,316.50
Aug 4, 2020	IDA-58360	Loan Disb	4,309,549.50
Nov 24, 2020	IDA-58360	Loan Disb	1,669,815.80
Nov 25, 2020	IDA-58360	Loan Disb	230,595.98
Feb 15, 2021	IDA-58360	Int Charges	9,936.61
Feb 15, 2021	IDA-58360	Int Charges	9,936.61
Feb 15, 2021	IDA-58360	Int Charges	351,379.47
Feb 15, 2021	IDA-58360	Int Charges	351,379.47
Feb 26, 2021	IDA-58360	Loan Disb	615,030.60
Oct 13, 2020	IDA-58360	Loan Disb	1,530,765.90
Aug 15, 2020	IDA-58360	Int Charges	1,126.90
Aug 15, 2020	IDA-58360	Int Charges	1,126.90
Aug 15, 2020	IDA-58360	Int Charges	297,266.84
Aug 15, 2020	IDA-58360	Int Charges	297,266.84
Dec 29, 2020	IDA-58360	Loan Disb	8,688,802.00
Mar 10, 2020	IDA-58360	Loan Disb	392,193.72
Jul 9, 2024	IDA-58360	Loan Disb	-250,851.69
Jun 15, 2016	IDA-58360	Loan Commitment	150,000,000.00
Aug 15, 2024	IDA-58360	Int Charges	394,766.53
Aug 15, 2024	IDA-58360	Int Charges	394,766.53
Aug 15, 2024	IDA-58360	Loan Repay	48,005.59
Aug 15, 2024	IDA-58360	Loan Repay	2,050,583.80
Feb 15, 2024	IDA-58360	Loan Repay	2,184,225.80
Feb 15, 2024	IDA-58360	Int Charges	463,014.56
Feb 15, 2024	IDA-58360	Int Charges	463,014.56
Feb 15, 2024	IDA-58360	Loan Repay	4,627.85
Sep 29, 2023	IDA-58360	Loan Cancel	6,856,535.50
Dec 18, 2023	IDA-58360	Loan Disb	-10,057,792.00
Feb 15, 2023	IDA-58360	Loan Repay	23,338.14
Feb 15, 2023	IDA-58360	Loan Repay	2,189,607.80

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Project Management	Moderately Satisfactory	2023-09-29
Monitoring and Evaluation	Moderately Satisfactory	2023-09-29
Overall Implementation Progress (IP)	Moderately Satisfactory	2023-09-29
Progress towards achievement of PDO	Moderately Satisfactory	2023-09-29
Procurement	Moderately Satisfactory	2023-09-29
Financial Management	Moderately Satisfactory	2023-09-29

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 05-29-2024
Outcomes	Substantial
Risk to Development Outcome
Bank Performance	Substantial
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 10-08-2024	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Moderately Satisfactory	N/a
Risk To Development Outcome		N/a
Bank Performance	Satisfactory	N/a
Borrower Performance		N/a
Government Performance		N/a
Implementing Agency		N/a
Icr Quality	Substantial	N/a
M&e Quality	Substantial	N/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Children immunized with the third dose of Pentavalent Value 79.50 85.40 83.00
Date December 31, 2015 September 30, 2023 December 31, 2019
Comment
Reported suspected cases of COVID-19 cases investigated based on national guidelines Value 0.00 100.00 0.00
Date October 20, 2020 September 30, 2023
Comment
Pregnant women attending at least four ANC visits Value 39.70 53.80 52.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment
Births attended by skilled health personnel Value 57.00 75.50 67.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment
Women between the ages of 15-49 years currently using a modern FP method Value 47.80 37.70 52.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment
Inspected facilities meeting safety standards Value 0.00 37.00 0.00
Date December 31, 2015 September 30, 2023
Comment
Pregnant women attending ANC supplemented with IFA Value 31.00 74.00 73.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Facilities inspected for safety standards Value 0.00 6932.00 1635.00
Date March 11, 2016 September 30, 2023 June 24, 2019
Comment
Functional community units Value 302.00 9400.00 5331.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment
Designated laboratories with COVID diagnostic equipment Value 2.00 41.00 0.00
Date March 18, 2020 September 30, 2023
Comment
Reports submitted to DHIS in a timely manner. Value 88.80 98.40 98.00
Date December 31, 2015 September 30, 2023 June 24, 2019
Comment
Grievances registered related to delivery of project benefits that are addressed Value 0.00 100.00 30.00
Date December 31, 2015 September 30, 2023
Comment
Births registered within 6 months of occurrence Value 65.90 80.60 70.00
Date December 31, 2015 September 30, 2023
Comment
Implementing entities submitting the annual FM and technical report on time Value 0.00 100.00 95.00
Date March 11, 2016 September 30, 2023 June 24, 2019
Comment
Vulnerable and marginalized communities reached in their indigenous language Value 0.00 100.00 0.00
Date March 18, 2020 September 30, 2023
Comment
RMNCAH related operations research completed to inform policy/strategy Value 0.00 2.00 2.00
Date March 11, 2016 September 30, 2023 June 24, 2019
Comment
A benefit package developed, costed, and disseminated Value 0.00 1.00 0.00
Date March 11, 2016 September 30, 2023
Comment
Lessons learned from UHC Phase I documented and disseminated Value No Yes
Date June 20, 2019 September 30, 2023
Comment
People who have received essential health, nutrition, and population (HNP) services Value 0.00 15394537.00 3800000.00
Date September 29, 2016 September 30, 2023
Comment
Number of children immunized Value 0.00 7639386.00 0.00
Date September 29, 2016 September 30, 2023
Comment
Number of deliveries attended by skilled health personnel Value 0.00 7755151.00 0.00
Date September 29, 2016 September 30, 2023
Comment

Children immunized with the third dose of Pentavalent	Value	79.50	85.40	83.00
	Date	December 31, 2015	September 30, 2023	December 31, 2019
	Comment

Reported suspected cases of COVID-19 cases investigated based on national guidelines	Value	0.00	100.00	0.00
	Date	October 20, 2020	September 30, 2023
	Comment

Pregnant women attending at least four ANC visits	Value	39.70	53.80	52.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Births attended by skilled health personnel	Value	57.00	75.50	67.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Women between the ages of 15-49 years currently using a modern FP method	Value	47.80	37.70	52.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Pregnant women attending ANC supplemented with IFA	Value	31.00	74.00	73.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Functional community units	Value	302.00	9400.00	5331.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Designated laboratories with COVID diagnostic equipment	Value	2.00	41.00	0.00
	Date	March 18, 2020	September 30, 2023
	Comment

Reports submitted to DHIS in a timely manner.	Value	88.80	98.40	98.00
	Date	December 31, 2015	September 30, 2023	June 24, 2019
	Comment

Births registered within 6 months of occurrence	Value	65.90	80.60	70.00
	Date	December 31, 2015	September 30, 2023
	Comment

Number of children immunized	Value	0.00	7639386.00	0.00
	Date	September 29, 2016	September 30, 2023
	Comment